FR2809733B1 - Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants - Google Patents
Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondantsInfo
- Publication number
- FR2809733B1 FR2809733B1 FR0007113A FR0007113A FR2809733B1 FR 2809733 B1 FR2809733 B1 FR 2809733B1 FR 0007113 A FR0007113 A FR 0007113A FR 0007113 A FR0007113 A FR 0007113A FR 2809733 B1 FR2809733 B1 FR 2809733B1
- Authority
- FR
- France
- Prior art keywords
- toxin
- bont
- detecting
- determining
- peptide substrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
- G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0007113A FR2809733B1 (fr) | 2000-06-02 | 2000-06-02 | Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants |
US10/296,396 US7160982B2 (en) | 2000-06-02 | 2001-05-31 | Peptide substrate identified by type BoNT/B botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
CA002409964A CA2409964A1 (fr) | 2000-06-02 | 2001-05-31 | Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants |
EP01940658A EP1290020A1 (fr) | 2000-06-02 | 2001-05-31 | Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants |
JP2002500923A JP2003535103A (ja) | 2000-06-02 | 2001-05-31 | BoNT/B型のボツリヌス毒素により認識されるペプチド基質並びに前記毒素もしくは対応の阻害物質をアッセイ及び/もしくは検出する為のそれらの利用 |
PCT/FR2001/001698 WO2001092312A1 (fr) | 2000-06-02 | 2001-05-31 | SUBSTRAT PEPTIDIQUE RECONNU PAR LA TOXINE BOTULIQUE DE TYPE BoNT/B ET SON UTILISATION POUR DOSER ET/OU DETECTER LADITE TOXINE OU DES INHIBITEURS CORRESPONDANTS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0007113A FR2809733B1 (fr) | 2000-06-02 | 2000-06-02 | Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2809733A1 FR2809733A1 (fr) | 2001-12-07 |
FR2809733B1 true FR2809733B1 (fr) | 2004-04-30 |
Family
ID=8850925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0007113A Expired - Lifetime FR2809733B1 (fr) | 2000-06-02 | 2000-06-02 | Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants |
Country Status (6)
Country | Link |
---|---|
US (1) | US7160982B2 (fr) |
EP (1) | EP1290020A1 (fr) |
JP (1) | JP2003535103A (fr) |
CA (1) | CA2409964A1 (fr) |
FR (1) | FR2809733B1 (fr) |
WO (1) | WO2001092312A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE378596T1 (de) | 2000-09-25 | 2007-11-15 | U S Medical Res Inst Of Infect | Hoch-durchsatz assays für proteolytische aktivitäten von clostridium neurotoxinen |
US7183066B2 (en) * | 2002-09-27 | 2007-02-27 | Allergan, Inc. | Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins |
FR2869908B1 (fr) * | 2004-05-05 | 2006-07-28 | Pharmaleads | Substrat peptidique reconnu par la toxine botulique de type a, bont/a et son utilisation pour detecter et/ou doser ladite toxine ou des inhibiteurs de son activite |
US7875436B2 (en) | 2004-05-05 | 2011-01-25 | Pharmaleads | Peptide substrates recognizable by a botulinum toxin A, BoNT/A and the use thereof |
AU2006340711C1 (en) | 2005-04-05 | 2013-02-07 | Allergan, Inc. | Clostridial toxin activity assays |
ATE470857T1 (de) | 2005-04-05 | 2010-06-15 | Allergan Inc | Lipophile, farbstoffbasierte fret-assays für die clostridientoxinaktivität |
FR2931151A1 (fr) * | 2008-05-13 | 2009-11-20 | Pharmaleads Soc Par Actions Si | Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique |
JP4864064B2 (ja) | 2008-10-30 | 2012-01-25 | エムジーファーマ株式会社 | 抗糖尿病作用を有するペプチドおよびその用途 |
US10408837B2 (en) * | 2013-12-09 | 2019-09-10 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Peptide substrates recognizable by type E botulinum neurotoxin |
EP3312290A1 (fr) * | 2016-10-18 | 2018-04-25 | Ipsen Biopharm Limited | Dosage de clivage d'empeigne cellulaire |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4698327A (en) * | 1985-04-25 | 1987-10-06 | Eli Lilly And Company | Novel glycopeptide derivatives |
US5962637A (en) * | 1994-06-03 | 1999-10-05 | Microbiological Research Authority | Toxin assay |
GB9411138D0 (en) * | 1994-06-03 | 1994-07-27 | Microbiological Res Authority | Toxin assay |
US7332567B2 (en) * | 2001-08-28 | 2008-02-19 | Allergan, Inc. | Fret protease assays for clostridial toxins |
-
2000
- 2000-06-02 FR FR0007113A patent/FR2809733B1/fr not_active Expired - Lifetime
-
2001
- 2001-05-31 US US10/296,396 patent/US7160982B2/en not_active Expired - Fee Related
- 2001-05-31 CA CA002409964A patent/CA2409964A1/fr not_active Abandoned
- 2001-05-31 JP JP2002500923A patent/JP2003535103A/ja active Pending
- 2001-05-31 WO PCT/FR2001/001698 patent/WO2001092312A1/fr active Application Filing
- 2001-05-31 EP EP01940658A patent/EP1290020A1/fr not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JP2003535103A (ja) | 2003-11-25 |
CA2409964A1 (fr) | 2001-12-06 |
FR2809733A1 (fr) | 2001-12-07 |
EP1290020A1 (fr) | 2003-03-12 |
WO2001092312A1 (fr) | 2001-12-06 |
US7160982B2 (en) | 2007-01-09 |
US20040126810A1 (en) | 2004-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ3438A1 (fr) | Inhibiteurs peptidomimetiques de protease | |
FR2809733B1 (fr) | Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants | |
DZ2285A1 (fr) | Inhibiteurs de protéase de la cystéine. | |
DE69925091D1 (de) | Aktiver Pixelsensor für Farbdetektion | |
DE60126289D1 (de) | Navigationswerkzeug | |
WO2008041953A3 (fr) | Diagnostic et traitement de la dingue | |
DE60101738T2 (de) | Erfassungssystem für sortiervorrichtung | |
DE60140561D1 (de) | Steuergriff für vollwandresektionsvorrichtungen (ftrd) | |
DE60038403D1 (de) | Abtastende Fluoreszenznachweisvorrichtung für Mehrfachproben. | |
DE69905048D1 (de) | Optoelektronisches gerät zum nachweis von beschädigtem korn | |
FI982494A (fi) | Kulmanilmaisumenetelmä taivutuskoneita varten, kulmanilmaisulaite ja sen kulma-anturi | |
DE69933807D1 (de) | Peilgerät zum Verarbeiten von Messdaten | |
NO20006084L (no) | Optisk virkende deteksjonsanordning | |
NO20004449D0 (no) | FremgangsmÕte for Õ bestemme antibiotisk sensitivitet til bakterier | |
MA25758A1 (fr) | Inhibiteurs de protease. | |
FR2869908B1 (fr) | Substrat peptidique reconnu par la toxine botulique de type a, bont/a et son utilisation pour detecter et/ou doser ladite toxine ou des inhibiteurs de son activite | |
DE69927242D1 (de) | Zieldetektionsanordnung | |
NO20032599L (no) | Anordning til påvisning og lokalisering av lekkasjer | |
DZ2815A1 (fr) | Inhibiteurs de protéase. | |
EP1177535A4 (fr) | Procede de detection double de feuilles destine a une machine pour transaction automatique | |
DE60017484D1 (de) | Gerät zur Erfassung von Motorumdrehungen | |
EP1184463A4 (fr) | Procede de detection de l'interaction proteine-proteine | |
NO20013506D0 (no) | Fremgangsmåte til bestemmelse av mikrobiell kontaminering | |
EP1378754A4 (fr) | Capteur de detection de rotation | |
ATE431425T1 (de) | Schnelltest der antibiotika-empfindlichkeit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TQ | Partial transmission of property | ||
PLFP | Fee payment |
Year of fee payment: 17 |
|
PLFP | Fee payment |
Year of fee payment: 18 |